It was end of 2012, and any knowledgeable poster could tell it was more of a claim made by the news rather than him, there was no actual product in trials so 2 years was impossible.
PGD2 is moving forward heavily since then, Kythera like Fear said above is fast-tracking their product, they definitely know they are on to something here.
there is a clear open market for an inbetween product here, something better than FIN/MIN but not a full cure, seems like a 3 legged race between BIM, CB and SETI.
nothing was close like this before, in 2012 the only thing (seemingly) moving forward was Histogen, not a single other thing could be taken seriously and was just typical grey market stuff that the forum comes up with all the time like Equol.
PGD2 is moving forward heavily since then, Kythera like Fear said above is fast-tracking their product, they definitely know they are on to something here.
there is a clear open market for an inbetween product here, something better than FIN/MIN but not a full cure, seems like a 3 legged race between BIM, CB and SETI.
nothing was close like this before, in 2012 the only thing (seemingly) moving forward was Histogen, not a single other thing could be taken seriously and was just typical grey market stuff that the forum comes up with all the time like Equol.
Comment